About Ellume
Ellume is a company based in Brisbane (Australia) founded in 2010 by Sean Parsons.. Ellume has raised $5 million across 2 funding rounds from investors including HHS and U.S. Department of Defense. Ellume offers products and services including Betting Reviews and Casino Guides. Ellume operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, GNA Biosolutions, Quantalife and Senzo, among others.
- Headquarter Brisbane, Australia
- Founders Sean Parsons
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ellume Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 2 rounds
-
Latest Funding Round
$230 M (USD), Grant
Feb 01, 2021
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ellume
Ellume offers a comprehensive portfolio of products and services, including Betting Reviews and Casino Guides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for comparing international betting sites and bonuses.
Guides on unlicensed casinos with payment options and odds.
Unlock access to complete
Unlock access to complete
Funding Insights of Ellume
Ellume has successfully raised a total of $5M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $230 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $230.0M
-
First Round
First Round
(17 Jun 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Grant - Ellume | Valuation |
investors |
|
| Jun, 2019 | Amount | Series A - Ellume | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ellume
Ellume has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and U.S. Department of Defense. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Military forces are provided by the U.S. Department of Defense for national security.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ellume
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ellume
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ellume Comparisons
Competitors of Ellume
Ellume operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, GNA Biosolutions, Quantalife and Senzo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Instruments and assays for molecular pathogen detection are developed.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ellume
Frequently Asked Questions about Ellume
When was Ellume founded?
Ellume was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Where is Ellume located?
Ellume is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Is Ellume a funded company?
Ellume is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jun 17, 2019.
What does Ellume do?
Ellume has is a developer of a diagnostic device that uses quantum dot fluorescent nanoparticles as biological detectors. It provides real-time patient testing with features such as encrypted patient data and images, connectivity to access user information, and claims to provides results in approximately seven minutes. The company has developed tests for Influenza AB, Respiratory Syncytial Virus, Group A Streptococcus, and aims to create tests for more respiratory viruses and bacterial infections.
Who are the top competitors of Ellume?
Ellume's top competitors include Souzhou Ribo Life Science, Tethis and Quantalife.
What products or services does Ellume offer?
Ellume offers Betting Reviews and Casino Guides.
Who are Ellume's investors?
Ellume has 2 investors. Key investors include HHS, and U.S. Department of Defense.